The National Times - Bumper potato harvests spell crisis for European farmers

Bumper potato harvests spell crisis for European farmers


Bumper potato harvests spell crisis for European farmers
Bumper potato harvests spell crisis for European farmers / Photo: © AFP/File

Farmers across Europe are protesting amid one of the most plentiful potato harvests in years, as the unintended consequences of US tariffs and increased competition drive down prices.

Change text size:

More than twenty tonnes of potatoes were dumped in front of the National Assembly in Paris last month, heaped into piles and peppered with French and trade union flags, in a vivid display of farmers' frustrations.

"It costs us less to give these potatoes to Parisians than to store them ourselves," Denis Lavenant, a farmer from the Yvelines region, told AFP.

Belgian farmers also handed out potatoes to passers-by on a Flanders highway, coupled with leaflets denouncing crashing prices and EU free trade agreements.

The sector is facing a "real challenge this year", Francois-Xavier Broutin, the director of economic affairs at CNIPT, which represents the French potato industry, told AFP.

The main reason, he said, was "the imbalance between supply and demand".

- French fry trade wars -

The North-Western European Potato Growers (NEPG) network, which brings together the four leading European producers (Germany, France, Belgium, and the Netherlands), has been warning about overproduction on the continent for months.

In these countries, which account for two-thirds of European production, the volumes harvested in 2025 are approaching 30 million tonnes, a 10 percent increase year-on-year.

"What's unusual about this season is that the harvest is abundant in all the major producing countries," said Boutin, who added that Germany, the leading European producer, is having its "best harvest in 25 years".

But with demand weakening across the continent, that increase in supply has been cause for concern rather than celebration.

Demand has dropped, the NEPG says, due to several factors: Weaker demand for frozen french fries after US tariffs imposed by President Donald Trump; "a strong euro against the dollar" hurting European exports overall; and increased production from foreign competitors including China, India, Egypt and Turkey.

The growers' network claims that in the past two years, China and India, the world's two leading producers, have "increased their frozen French fry exports to neighbouring countries tenfold," while EU exports declined.

For Broutin, however, the crisis is only temporary, as "global demand continues to rise," which he believes will eventually catch up to increasing potato volumes.

- Farmers urged to reconsider -

While that suggests the European potato sector is not under threat in the long-term, farmers are still feeling the immediate consequences.

At the end of last year, the NEPG network bluntly asked European farmers if they were ready to "produce while losing money".

Two months later, as the March-April planting season approaches, there are clear signals that farmers may have to reconsider how much land they will dedicate to potatoes.

In France, the UNPT, the main producers' association, is denouncing both a decline in the number of contractual agreements, which would guarantee farmers a price negotiated in advance, and a 25 percent drop in the contract prices offered.

The price of a tonne of Fontane potatoes, one of the main cultivated varieties, is expected to drop to around 130 euros in 2026 from 180 euros last year, according to the UNPT.

A.Wood--TNT

Featured

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Change text size: